Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on December 15, 2020. The report addresses a specific corporate governance event regarding the company's listing status on the Nasdaq Stock Market. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only financial metric disclosed is the stock price performance required for regulatory compliance.
Material Changes
- Regulatory Compliance: The company regained compliance with Nasdaq Listing Rule 5550(a)(2).
- Stock Price Performance: The closing bid price of the common stock was at or above $1.00 per share for 10 consecutive business days (December 1, 2020, to December 14, 2020).
- Resolution of Deficiency: This resolves a previous notice of non-compliance issued by Nasdaq on October 1, 2020, regarding failure to maintain a $1.00 bid price over a 30-day period.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of risks and contingencies beyond the resolution of the listing deficiency. The matter regarding the bid price deficiency is now closed.
Investor Verification Checklist
- Verify the current trading status of Second Sight Medical Products, Inc. (EYES) on Nasdaq.
- Confirm the company's current stock price relative to the $1.00 minimum bid requirement.
- Review subsequent filings to ensure no new delisting notices have been issued.
- Clarify the discrepancy between the requested company name (Vivani Medical) and the filing registrant (Second Sight Medical).